MedDataX Logo

The Efficacy of the Acupuncture in the Treatment of Systemic Arterial Hypertension

NCT ID: NCT03512106

Last Updated: 2018-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

86 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-01

Study Completion Date

2019-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are few studies in the treatment of hypertension employing acupuncture as a blood pressure regulating technique. The Ministry of Health synthesized the inclusion of integrative and complementary practices within the Unique Health System, such as acupuncture. Our objective is to verify the effect of the acupuncture session on hypertensive patients, measured through ambulatory blood pressure monitoring (ABPM). In this way two groups of patients will be selected in a randomized clinical trial. In the first group, Chinese traditional acupuncture will be applied and in the second group the acupuncture sham will be applied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acupuncture as therapy is the subject of conflicting opinions on its effectiveness in scientific means, because in spite of its long existence as a therapeutic tool, raises doubts on the standards of Western science model. In addition, there are few studies in the treatment of hypertension employing Acupuncture as a blood pressure regulating technique. The Ministry of Health synthesized the inclusion of integrative and complementary practices within the Unique Health System, such as Acupuncture. The World Health Organization (WHO) recognizes its effectiveness, having its own concept in the energy imbalance that alter the organic, mental and emotional part addressing a current issue proposing to groundbreaking research. The objective is to verify the effect of the acupuncture session on hypertensive patients, measured through ambulatory blood pressure monitoring (ABPM). In this way two groups of patients will be selected in a randomized clinical trial. In the first group, Chinese traditional acupuncture will be applied and in the second group the acupuncture sham will be applied.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arterial Hypertension

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Arterial Hypertension Acupuncture

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Chinese traditional acupuncture will be applied.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
Acupuncture sham will be applied (placebo).

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acupuncture group

Chinese traditional acupuncture

Group Type EXPERIMENTAL

Acupuncture

Intervention Type OTHER

Chinese traditional acupuncture

Sham group

Sham

Group Type PLACEBO_COMPARATOR

Acupuncture

Intervention Type OTHER

Chinese traditional acupuncture

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acupuncture

Chinese traditional acupuncture

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients enrolled in stage I to III of systemic arterial hypertension
* signing the free and informed consent term

Exclusion Criteria

* patients who do not agree to participate in the study
* patients with systolic pressure values greater than 180 mmHg or diastolic pressure above 110 mmHg
* patients with important comorbidities
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

silvia goldmeier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

silvia goldmeier

PhD

Responsibility Role SPONSOR_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Silvia Goldmeier, PhD

Role: CONTACT

Phone: +5551992431342

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Acupuncture

Identifier Type: -

Identifier Source: org_study_id